Skip to NavigationSkip to content

Thyroid medication recalled after Chinese supplier fails inspection

Published on 20/08/18 at 10:52am

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly Pharmaceutical Co failed an FDA inspection.

Sichuan Pharmaceutical who supplied Westminster with an Active Pharmaceutical Ingredient (API) used in the production of certain thyroid medications were found to have deficiencies with Current Good Manufacturing Practices (cGMP) and thus could pose a risk to patient safety.

As of yet there have been no reported adverse events in relation to the medications. The fda warned that “Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product.”

Westminster has told its wholesalers to immediately stop distributing the medications involved while also making arrangements for already distributed products to be returned.

The recall comes as drug safety scandals have plagued Chinese manufacturers in recent months. While protests erupted in Beijing over Changsheng Biotechnology’s corrupt practices, regulators recalled Chinese produced valsartan after it was found that some batches may be contaminated with carcinogens.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches